Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients
Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients
复制标题
DOI：
10.1016/j.jpainsymman.2003.10.009
复制
发表时间：
2004-05-01
影响因子：
4.7
通讯作者：
Noe, C
中科院分区：
文献类型：
--
作者：
Adams, LL;Gatchel, R;Noe, C
这项研究构成了心理测量学发展的第一步，自我报告筛选工具的风险阿片类药物滥用慢性疼痛患者。一个26项的工具，疼痛用药问卷（PMQ），构建了基于阿片类药物滥用，迄今为止已收到有限的实证调查的可疑行为相关。PMQ在一个跨学科疼痛治疗中心对184名患者进行了管理。PMQ的可靠性系数被认为是中等的，但可以接受的强度。通过PMQ分数与物质滥用、身体和心理功能以及医生风险评估的相关性来检查结构和并行效度。为了探索误用风险的高和低临界点，根据PMQ得分的上三分之一和下三分之一形成亚组，并在有效性测量上进行比较。较高的PMQ分数与药物滥用史、较高的心理社会困扰水平和较差的功能有关。未来的心理测量分析将考虑预测有效性，并检查该工具的缩短版本。(C)2004年美国癌症疼痛缓解委员会。爱思唯尔公司出版All rights reserved.
This study constituted the first step in the psychometric development of a self-report screening instrument for risk of opioid medication misuse among chronic pain patients. A 26-item instrument, the Pain Medication Questionnaire (PMQ), was constructed based on suspected behavioral correlates of opioid medication misuse, which heretofore have received limited empirical investigation. The PMQ was administered to 184 patients at an interdisciplinary pain treatment center. Reliability coefficients for the PMQ were found to be of moderate but acceptable strength. Construct and concurrent validity were examined through correlation of PMQ scores to measures of substance abuse, physical and psychological functioning, and physicians' risk assessments. To explore high and low cutoff points for misuse risk, subgroups were formed according to the upper and lower thirds of PMQ scores and compared on validity measures. Higher PMQ scores were associated with history of substance abuse, higher levels of psychosocial distress, and poorer functioning. future psychometric analyses will consider predictive validity and examine shortened versions of the instrument. (C) 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.